BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 1553856)

  • 1. The pharmacokinetics and effects of prochlorperazine in elderly female volunteers.
    Isah AO; Rawlins MD; Bateman DN
    Age Ageing; 1992 Jan; 21(1):27-31. PubMed ID: 1553856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical pharmacology of prochlorperazine in healthy young males.
    Isah AO; Rawlins MD; Bateman DN
    Br J Clin Pharmacol; 1991 Dec; 32(6):677-84. PubMed ID: 1768559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary studies of the pharmacokinetics and pharmacodynamics of prochlorperazine in healthy volunteers.
    Taylor WB; Bateman DN
    Br J Clin Pharmacol; 1987 Feb; 23(2):137-42. PubMed ID: 3828192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prochlorperazine as a doxorubicin-efflux blocker: phase I clinical and pharmacokinetics studies.
    Sridhar KS; Krishan A; Samy TS; Sauerteig A; Wellham LL; McPhee G; Duncan RC; Anac SY; Ardalan B; Benedetto PW
    Cancer Chemother Pharmacol; 1993; 31(6):423-30. PubMed ID: 8453681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pharmacokinetics and bioavailability of prochlorperazine delivered as a thermally generated aerosol in a single breath to volunteers.
    Avram MJ; Spyker DA; Henthorn TK; Cassella JV
    Clin Pharmacol Ther; 2009 Jan; 85(1):71-7. PubMed ID: 18830225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prochlorperazine induces akathisia in emergency patients.
    Drotts DL; Vinson DR
    Ann Emerg Med; 1999 Oct; 34(4 Pt 1):469-75. PubMed ID: 10499947
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability and metabolism of prochlorperazine administered via the buccal and oral delivery route.
    Finn A; Collins J; Voyksner R; Lindley C
    J Clin Pharmacol; 2005 Dec; 45(12):1383-90. PubMed ID: 16291713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of prochlorperazine and dipyridamole on the cellular retention and cytotoxicity of doxorubicin.
    Krishan A; Sridhar KS; Mou C; Stein WD; Lyubimov E; Hu YP; Fernandez H
    Clin Cancer Res; 2000 Apr; 6(4):1508-17. PubMed ID: 10778983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients.
    Stangier J; Su CA; Roth W
    J Int Med Res; 2000; 28(4):149-67. PubMed ID: 11014323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recirculatory pharmacokinetic model of the uptake, distribution, and bioavailability of prochlorperazine administered as a thermally generated aerosol in a single breath to dogs.
    Avram MJ; Henthorn TK; Spyker DA; Krejcie TC; Lloyd PM; Cassella JV; Rabinowitz JD
    Drug Metab Dispos; 2007 Feb; 35(2):262-7. PubMed ID: 17079359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of prochlorperazine buccal tablets (Bukatel) and metoclopramide oral tablets in the treatment of acute emesis.
    Singh S; Sharma DR; Chaudhary A
    J Indian Med Assoc; 1999 Aug; 97(8):346-7. PubMed ID: 10643185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of DP-b99 in healthy volunteers: first administration to humans.
    Rosenberg G; Angel I; Kozak A
    Br J Clin Pharmacol; 2005 Jul; 60(1):7-16. PubMed ID: 15963088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of the psychometric effects of chlormethiazole in healthy young and elderly subjects.
    Fagan D; Lamont M; Jostell KG; Tiplady B; Scott DB
    Age Ageing; 1990 Nov; 19(6):395-402. PubMed ID: 2285007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phase I study of carboplatin and etoposide administered in conjunction with dipyridamole, prochlorperazine and cyclosporine A.
    Raschko JW; Synold TW; Chow W; Coluzzi P; Hamasaki V; Leong LA; Margolin KA; Morgan RJ; Shibata SI; Somlo G; Tetef ML; Yen Y; ter Veer A; Doroshow JH
    Cancer Chemother Pharmacol; 2000; 46(5):403-10. PubMed ID: 11127945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic study of omeprazole in elderly healthy volunteers.
    Landahl S; Andersson T; Larsson M; Lernfeldt B; Lundborg P; Regårdh CG; Sixt E; Skånberg I
    Clin Pharmacokinet; 1992 Dec; 23(6):469-76. PubMed ID: 1458764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repurposing of prochlorperazine for use against dengue virus infection.
    Simanjuntak Y; Liang JJ; Lee YL; Lin YL
    J Infect Dis; 2015 Feb; 211(3):394-404. PubMed ID: 25028694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and tolerance of single- and multiple-dose oral or intravenous linezolid, an oxazolidinone antibiotic, in healthy volunteers.
    Stalker DJ; Jungbluth GL; Hopkins NK; Batts DH
    J Antimicrob Chemother; 2003 May; 51(5):1239-46. PubMed ID: 12668582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of sulpiride on vigilance in healthy subjects.
    Bartfai A; Wiesel FA
    Int J Psychophysiol; 1986 May; 4(1):1-5. PubMed ID: 3721942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single dose pharmacokinetics of cetirizine in young and elderly volunteers.
    Lefebvre RA; Rosseel MT; Bernheim J
    Int J Clin Pharmacol Res; 1988; 8(6):463-70. PubMed ID: 2908109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.